Virus Shot From Pfizer, BioNtech Shows Promise in Early Test

This post was originally published on this site

An early trial of an experimental coronavirus vaccine from Pfizer Inc. and BioNtech SE showed it’s safe and prompted patients to produce antibodies against the new virus, keeping it in the lead pack for a pandemic shot. The messenger RNA product was …

Click here to read full article